KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Payables (2016 - 2026)

Chemed filings provide 18 years of Payables readings, the most recent being $65.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Payables rose 37.75% year-over-year to $65.7 million, compared with a TTM value of $65.7 million through Mar 2026, up 37.75%, and an annual FY2025 reading of $64.5 million, up 46.01% over the prior year.
  • Payables hit $65.7 million in Q1 2026 for Chemed, up from $64.5 million in the prior quarter.
  • The five-year high for Payables was $77.2 million in Q3 2022, with the low at $40.3 million in Q1 2023.
  • Median Payables over the past 5 years was $50.9 million (2025), compared with a mean of $54.4 million.
  • The largest YoY upside for Payables was 52.88% in 2023 against a maximum downside of 44.5% in 2023.
  • Year by year, Payables stood at $41.9 million in 2022, then surged by 52.88% to $64.0 million in 2023, then plummeted by 31.06% to $44.1 million in 2024, then surged by 46.01% to $64.5 million in 2025, then increased by 1.92% to $65.7 million in 2026.
  • According to Business Quant data, Payables over the past three periods came in at $65.7 million, $64.5 million, and $48.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.